Skip to content

Clinical trials

Pulmonary Fibrosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Country / region: Germany Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20071
20081
20101
20112
20132
20171
20191
20203
20213
20221
20234
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Terminated5
Recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim5
Bristol-Myers Squibb4
Schön Klinik Berchtesgadener Land2
Amgen1
Avalyn Pharma Inc.1
Celgene1
Centocor, Inc.1
Endeavor Biomedicines, Inc.1
Erasmus Medical Center1
Kyntra Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis24
Idiopathic Pulmonary Fibrosis12
Lung Diseases, Interstitial7
Idiopathic Interstitial Pneumonias3
COVID-192
Fibrosis2
Pulmonary Disease, Chronic Obstructive2
Alveolitis, Extrinsic Allergic1
Anxiety Disorders1
Arthritis, Rheumatoid1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.